Market Overview:
The global piperacillin sodium market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of infectious diseases, rising demand for piperacillin sodium in hospitals and clinics, and growing investments by key players in R&D activities. However, the high cost of treatment is likely to restrain the growth of this market during the forecast period. On the basis of type, 98% purity type held a major share of the global piperacillin sodium market in 2017. This segment is projected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. Piperacillin Sodium Sulbactam Sodium Injection 8:1 was one of most commonly used formulations in this segment owing its high efficacy against various types bacteria strains including MRSA (methicillin-resistant Staphylococcus aureus).
 Industry Outlook.svg)
Product Definition:
Piperacillin Sodium (CAS 59703-84-3) is a semisynthetic penicillin antibiotic. It inhibits the synthesis of bacterial cell wall. Piperacillin sodium is used to treat a wide variety of bacterial infections, including those caused by E. coli, P.
98% Purity Type:
98% purity type is a form of piperacillin sodium that has been processed to remove all other compounds. It is used as an antibiotic and its applications are spread across the medical sector. 98% pure type has applications in the treatment of urinary tract infections, skin infections, pneumonia, and bronchitis among others. The growth factor for this market is increasing demand from emerging economies such as China & India due to rising disposable income coupled with growing awareness about antibiotics in these countries.
95% Purity Type:
95% Purity type is a form of piperacillin sodium that has been processed to remove all other compounds except for piperacillin. It is used as an intravenous antibiotic and it works by inhibiting the action of penicillin-binding proteins in the human body.
The product finds application in the treatment of bacterial infections throughout the world, especially in countries with poor healthcare infrastructure such as India, China.
Application Insights:
Piperacillin sodium is used for the treatment of various infections caused by susceptible bacteria including Staphylococcus aureus, Streptococcus pneumoniae, and Escherichia coli. The product finds application in parenteral nutrition therapy as well as in surgical procedures. Surgical applications include orthopedic surgeries such as knee & hip replacement and spinal fusion surgery. Piperacillin sodium injection 8:1 is commonly used for the treatment of skin & skin structure infection (SSSI) due to its high penetration through the skin owing to which it is highly preferred over other antibiotics for this purpose.
The others segment mainly includes ventilator-associated pneumonia (VAP) due to viruses such as adenovirus, rhinovirus, and coronavirus that are known to cause respiratory tract infections among patients who have undergone mechanical ventilation procedures or suffer from diseases such as cystic fibrosis or lung cancer during their recovery process at a hospital.
Regional Analysis:
North America dominated the global piperacillin sodium market in terms of revenue with a share of over 40.0% in 2017. This is attributed to the presence of a large number of manufacturers coupled with high product penetration and usage rates for veterinary as well as human medicine applications. The U.S.
Asia Pacific region is anticipated to witness significant growth owing to increasing healthcare expenditure levels by governments.
Growth Factors:
- Increasing demand for piperacillin sodium in the treatment of various infections
- Rising prevalence of infectious diseases
- Growing number of hospital-acquired infections (HAIs)
- Technological advancements in piperacillin sodium manufacturing process
- Rising healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Piperacillin Sodium (CAS 59703-84-3) Market Research Report
By Type
98% Purity Type, 95% Purity Type, Others
By Application
Piperacillin Sodium Sulbactam Sodium Injection 8:1, Piperacillin Sodium Sulbactam Sodium Injection 4:1, Piperacillin Sodium Sulbactam Sodium Injection 2:1, Others
By Companies
CSPC, Clearsynth, Hai Rui, A Chemtek, ALSA Chim, Muse Chem, Selleck Chem, Biosynth, 3B Scientific, LGC Standards, TargetMol, CSNpharm, Aurora Fine Chemicals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Piperacillin Sodium (CAS 59703-84-3) Market Report Segments:
The global Piperacillin Sodium (CAS 59703-84-3) market is segmented on the basis of:
Types
98% Purity Type, 95% Purity Type, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Piperacillin Sodium Sulbactam Sodium Injection 8:1, Piperacillin Sodium Sulbactam Sodium Injection 4:1, Piperacillin Sodium Sulbactam Sodium Injection 2:1, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- CSPC
- Clearsynth
- Hai Rui
- A Chemtek
- ALSA Chim
- Muse Chem
- Selleck Chem
- Biosynth
- 3B Scientific
- LGC Standards
- TargetMol
- CSNpharm
- Aurora Fine Chemicals
 Market Overview.svg)
Highlights of The Piperacillin Sodium (CAS 59703-84-3) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 98% Purity Type
- 95% Purity Type
- Others
- By Application:
- Piperacillin Sodium Sulbactam Sodium Injection 8:1
- Piperacillin Sodium Sulbactam Sodium Injection 4:1
- Piperacillin Sodium Sulbactam Sodium Injection 2:1
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Piperacillin Sodium (CAS 59703-84-3) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Piperacillin sodium is a penicillin antibiotic. It is used to treat infections caused by bacteria.
Some of the key players operating in the piperacillin sodium (cas 59703-84-3) market are CSPC, Clearsynth, Hai Rui, A Chemtek, ALSA Chim, Muse Chem, Selleck Chem, Biosynth, 3B Scientific, LGC Standards, TargetMol, CSNpharm, Aurora Fine Chemicals.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Piperacillin Sodium (CAS 59703-84-3) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Piperacillin Sodium (CAS 59703-84-3) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Piperacillin Sodium (CAS 59703-84-3) Market - Supply Chain
4.5. Global Piperacillin Sodium (CAS 59703-84-3) Market Forecast
4.5.1. Piperacillin Sodium (CAS 59703-84-3) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Piperacillin Sodium (CAS 59703-84-3) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Piperacillin Sodium (CAS 59703-84-3) Market Absolute $ Opportunity
5. Global Piperacillin Sodium (CAS 59703-84-3) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Piperacillin Sodium (CAS 59703-84-3) Market Size and Volume Forecast by Type
5.3.1. 98% Purity Type
5.3.2. 95% Purity Type
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Piperacillin Sodium (CAS 59703-84-3) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Piperacillin Sodium (CAS 59703-84-3) Market Size and Volume Forecast by Application
6.3.1. Piperacillin Sodium Sulbactam Sodium Injection 8:1
6.3.2. Piperacillin Sodium Sulbactam Sodium Injection 4:1
6.3.3. Piperacillin Sodium Sulbactam Sodium Injection 2:1
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Piperacillin Sodium (CAS 59703-84-3) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Piperacillin Sodium (CAS 59703-84-3) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Piperacillin Sodium (CAS 59703-84-3) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Piperacillin Sodium (CAS 59703-84-3) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Piperacillin Sodium (CAS 59703-84-3) Demand Share Forecast, 2019-2026
9. North America Piperacillin Sodium (CAS 59703-84-3) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Piperacillin Sodium (CAS 59703-84-3) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Piperacillin Sodium (CAS 59703-84-3) Market Size and Volume Forecast by Application
9.4.1. Piperacillin Sodium Sulbactam Sodium Injection 8:1
9.4.2. Piperacillin Sodium Sulbactam Sodium Injection 4:1
9.4.3. Piperacillin Sodium Sulbactam Sodium Injection 2:1
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Piperacillin Sodium (CAS 59703-84-3) Market Size and Volume Forecast by Type
9.7.1. 98% Purity Type
9.7.2. 95% Purity Type
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Piperacillin Sodium (CAS 59703-84-3) Demand Share Forecast, 2019-2026
10. Latin America Piperacillin Sodium (CAS 59703-84-3) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Piperacillin Sodium (CAS 59703-84-3) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Piperacillin Sodium (CAS 59703-84-3) Market Size and Volume Forecast by Application
10.4.1. Piperacillin Sodium Sulbactam Sodium Injection 8:1
10.4.2. Piperacillin Sodium Sulbactam Sodium Injection 4:1
10.4.3. Piperacillin Sodium Sulbactam Sodium Injection 2:1
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Piperacillin Sodium (CAS 59703-84-3) Market Size and Volume Forecast by Type
10.7.1. 98% Purity Type
10.7.2. 95% Purity Type
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Piperacillin Sodium (CAS 59703-84-3) Demand Share Forecast, 2019-2026
11. Europe Piperacillin Sodium (CAS 59703-84-3) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Piperacillin Sodium (CAS 59703-84-3) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Piperacillin Sodium (CAS 59703-84-3) Market Size and Volume Forecast by Application
11.4.1. Piperacillin Sodium Sulbactam Sodium Injection 8:1
11.4.2. Piperacillin Sodium Sulbactam Sodium Injection 4:1
11.4.3. Piperacillin Sodium Sulbactam Sodium Injection 2:1
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Piperacillin Sodium (CAS 59703-84-3) Market Size and Volume Forecast by Type
11.7.1. 98% Purity Type
11.7.2. 95% Purity Type
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Piperacillin Sodium (CAS 59703-84-3) Demand Share, 2019-2026
12. Asia Pacific Piperacillin Sodium (CAS 59703-84-3) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Piperacillin Sodium (CAS 59703-84-3) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Piperacillin Sodium (CAS 59703-84-3) Market Size and Volume Forecast by Application
12.4.1. Piperacillin Sodium Sulbactam Sodium Injection 8:1
12.4.2. Piperacillin Sodium Sulbactam Sodium Injection 4:1
12.4.3. Piperacillin Sodium Sulbactam Sodium Injection 2:1
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Piperacillin Sodium (CAS 59703-84-3) Market Size and Volume Forecast by Type
12.7.1. 98% Purity Type
12.7.2. 95% Purity Type
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Piperacillin Sodium (CAS 59703-84-3) Demand Share, 2019-2026
13. Middle East & Africa Piperacillin Sodium (CAS 59703-84-3) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Piperacillin Sodium (CAS 59703-84-3) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Piperacillin Sodium (CAS 59703-84-3) Market Size and Volume Forecast by Application
13.4.1. Piperacillin Sodium Sulbactam Sodium Injection 8:1
13.4.2. Piperacillin Sodium Sulbactam Sodium Injection 4:1
13.4.3. Piperacillin Sodium Sulbactam Sodium Injection 2:1
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Piperacillin Sodium (CAS 59703-84-3) Market Size and Volume Forecast by Type
13.7.1. 98% Purity Type
13.7.2. 95% Purity Type
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Piperacillin Sodium (CAS 59703-84-3) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Piperacillin Sodium (CAS 59703-84-3) Market: Market Share Analysis
14.2. Piperacillin Sodium (CAS 59703-84-3) Distributors and Customers
14.3. Piperacillin Sodium (CAS 59703-84-3) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. CSPC
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Clearsynth
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Hai Rui
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. A Chemtek
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. ALSA Chim
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Muse Chem
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Selleck Chem
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Biosynth
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. 3B Scientific
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. LGC Standards
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. TargetMol
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. CSNpharm
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Aurora Fine Chemicals
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
